Energizing Advocacy
Elevating Priorities
2018 ANNUAL REPORT WINNING HEARTS and MINDS for RESEARCH
Sustaining Hope Table of Contents
1 LETTER FROM LEADERSHIP 2 ADVOCACY OVERVIEW 3 CAPITOL HILL BRIEFINGS 4 BIPARTISAN CIVIC ENGAGEMENT 4 POST-ELECTION BRIEFING 5 NEW THINKING ON PERSISTENT CHALLENGES 6 2018 ADVOCACY AWARDS 7 EXPERTS DISCUSS SCIENCE ADVOCACY AND MENTAL HEALTH AT RESEARCH!AMERICA’S ANNUAL MEETING 8 WEBINARS 9 PUBLIC OPINION PARTNERSHIPS 10 SCIENCE COMMUNICATIONS PRESENTATIONS 10 PUBLIC HEALTH THANK YOU DAY 11 U.S. INVESTMENTS IN MEDICAL AND HEALTH RESEARCH AND DEVELOPMENT (R&D) 12 MEDIA MATTERS 13 FINANCIALS 14 2018 MAJOR DONORS, PARTNERS, AND CONTRIBUTORS 14 RESEARCH!AMERICA STAFF 15 BOARD OF DIRECTORS HOPE ACADEMIA DISCOVERY SURVEYS RESEARCH INSTITUTES THE RESEARCH!AMERICA RESEARCH FORUM PATIENTS ALLIANCE ADVOCATES FOR SCIENCE, DISCOVERY, AND PROGRESS RESEARCH BIPARTISAN HEALTH CARE INNOVATION TO ACHIEVE BETTER HEALTH FOR ALL. ALLIANCE INDUSTRY PATIENTS SCIENCE COALITION INNOVATION HEALTH ADVOCACY AWARDS 420 MEDICAL ADVOCACY MEMBERS WEEKLY LETTER PUBLIC HEALTH LEADERSHIP INVESTMENT Letter from Leadership
The year 2018 started with a warning shot across the bow: The United States dropped out of the top 10 list of “innovative countries” compiled by the Bloomberg Innovation Index. Also for the first time, China surpassed the United States in scientific publications and is ahead of schedule to outpace the United States in public resources committed to research and development (R&D) by the year 2020. Having anticipated these developments, Research!America, along with its members and partners, activated a public engagement and advocacy strategy. Letters were sent to new and incumbent candidates for the U.S. Congress, making the case for championing the nation’s way back to a position of strength in R&D leadership. With support from the Rita Allen Foundation and other partners, we launched a program of competitive micro-grants to enable science graduate and postdoctoral students to organize nonpartisan civic engagement activities leading up to the midterm elections.
Working with members and partners in Washington, D.C., we completed the “Raise the Caps” campaign that began in late 2017, aiming to increase the nondefense discretionary budget by $63 billion in fiscal year (FY) 2018 and $68 billion in FY19. This campaign brought science to the table in budget discussions, and made it possible for congressional champions to increase National Institutes of Health (NIH) funding by $3 billion in FY18 and by $2 billion in FY19. It also provided for increased funding across other key research and public health agencies. Our alliance was also active in winning a two-year suspension of the medical device tax. In addition, Research!America worked for the on-time passage of the U.S. House of Representatives Labor, Health and Human Services, Education, and Related Agencies (Labor-HHS) appropriations bill for the first time in 20 years!
Research!America partnered with members and allies to convene Capitol Hill briefings on health chal- lenges, calling attention to the importance of research-driven progress. Results from a Research!America public opinion survey show that 80% of Americans are (rightly) concerned about the health threat posed by antibiotic resistance; survey results also show continued high public regard for science and scientists. HHS Sec. Alex M. Azar II, along with other federal officials and industry thought leaders, joined the capac- ity crowd at the National Health Research Forum. We were pleased to welcome 30 new organizations to our alliance, bringing total membership to 420.
As Research!America enters its 30th anniversary year, we remain greatly concerned by the continued slippage of our nation’s global R&D and public health leadership. Also concerning is the disturbing news that life expectancy in the United States dropped for the third year in a row. Funding increases secured over the past years are notable, but in today’s hyper-competitive global environment, the United States will continue to fall behind if we don’t make research and innovation a higher national priority, as our competitors are doing!
The growing engagement of scientists in the nation’s civic life offers great optimism, as does the tireless commitment of Research!America’s allies in academia, patient organizations, philanthropy and industry. Working together, we will continue to pursue a policy agenda in which public- and private-sector medical innovation thrives, the nation’s public health capacity flourishes and our global R&D leadership strengthens.
On behalf of Research!America’s board and staff members, thank you for your ongoing partnership and support. We encourage you to stay the course with us in 2019 and beyond. Building a healthier, pros- perous and secure nation relies on finding solutions to what ails us. That’s research; that’s advocacy for research; that’s your Research!America.
The Honorable Mary Woolley Michael N. Castle President Chair and CEO
1
2
federal officials and committee staff. committee and officials federal
gave members an opportunity to hear from key key from hear to opportunity an members gave
clinical research and other timely issues, and that that and issues, timely other and research clinical
appropriations process, value-based purchasing, purchasing, value-based process, appropriations
members that featured content experts on the the on experts content featured that members
health progress. Meetings were held for alliance alliance for held were Meetings progress. health
SPECIAL EVENTS SPECIAL tor–fueled R&D underlying medical and public public and medical underlying R&D tor–fueled
34 34
- private-sec and public- of interplay the casing
- show briefings Hill Capitol four including tion,
AHRQ FUNDING AHRQ
- innova drives research how highlighting events
AND GREW AND
During 2018, Research!America held 34 special special 34 held Research!America 2018, During
STATEMENTS STATEMENTS
signatures were garnered, respectively. garnered, were signatures
PROTECTED PROTECTED
research agencies; more than 150 and 200 200 and 150 than more agencies; research
LETTERS AND AND LETTERS
funding for medical and public health–focused health–focused public and medical for funding
61 61
HHS subcommittees for their role in securing securing in role their for subcommittees HHS
DEVICE TAX DEVICE
ing members of the House and Senate Labor- Senate and House the of members ing
- rank and chairs the thank to spearheaded were
THE MEDICAL MEDICAL THE
administration. Two congressional sign-on letters letters sign-on congressional Two administration.
SUSPENSION OF OF SUSPENSION MEETINGS directed to members of Congress or the Trump Trump the or Congress of members to directed
YEAR YEAR and onto signed or sent were statements and
BRANCH BRANCH
and public education materials. Sixty-one letters letters Sixty-one materials. education public and
fact sheets, infographics, and other advocacy advocacy other and infographics, sheets, fact EXECUTIVE EXECUTIVE
TWO- new 61 published It officials. branch executive
70
sional meetings and held 70 meetings with with meetings 70 held and meetings sional
- congres 219 in participated Research!America
response and health economics research. economics health and response
and reduce resources for such priorities as Ebola Ebola as priorities such for resources reduce and 2 YEARS FOR NIH FOR YEARS 2 MEETINGS
Agency for Healthcare Research and Quality, Quality, and Research Healthcare for Agency
OVER INCREASE CONGRESSIONAL sought to limit fetal tissue research, defund the the defund research, tissue fetal limit to sought
bil $5 219
proposals from advancing, including those that that those including advancing, from proposals
also played a role in preventing several harmful harmful several preventing in role a played also
of the medical device excise tax. The alliance alliance The tax. excise device medical the of
FY19 respectively; and a two-year suspension suspension two-year a and respectively; FY19
billion and $2 billion increase for NIH in FY18 and and FY18 in NIH for increase billion $2 and billion
neering enterprise. neering
to raise the budget caps in FY18 and FY19; a $3 $3 a FY19; and FY18 in caps budget the raise to
- engi and science unparalleled States’s United
plishments in 2018, including a bipartisan deal deal bipartisan a including 2018, in plishments
and (4) a stronger national commitment to the the to commitment national stronger a (4) and
- accom policy and funding key achieving in role
is pivotal to the future of health and health care; care; health and health of future the to pivotal is
Research!America’s alliance played a prominent prominent a played alliance Research!America’s
health services and social sciences research that that research sciences social and services health
meet its multipronged, lifesaving mission; (3) (3) mission; lifesaving multipronged, its meet global leader in science and innovation. and science in leader global
public health system that is fully equipped to to equipped fully is that system health public the United States sustains its standing as the the as standing its sustains States United the
private-sector–driven medical discovery; (2) a a (2) discovery; medical private-sector–driven ing the nation’s public health system and assuring assuring and system health public nation’s the ing
efforts as it fights for (1) faster public- and and public- faster (1) for fights it as efforts - strengthen progress, medical speeding at aimed
expand and diversify its advocacy and policy policy and advocacy its diversify and expand diligently to advance funding and policy priorities priorities policy and funding advance to diligently
In 2019, Research!America will continue to to continue will Research!America 2019, In of more than 400 member organizations, worked worked organizations, member 400 than more of
In 2018, Research!America, along with our alliance alliance our with along Research!America, 2018, In LOOKING AHEAD LOOKING Advocacy Overview Advocacy Capitol Hill Briefings The Role of Research in Addressing Asthma Asthma is a chronic lung disease that affects and airway biology branch, National Institute more than 25 million Americans. The briefing, of Allergy and Infectious Disease; Rohit Katial, “From Discovery to Delivery: The Role of MD, allergist, U.S. medical respiratory expert, Research in Addressing Asthma,” was hosted GlaxoSmithKline; Cara Kraft, RRT/RCP, AE-C, by Research!America in partnership with director of research and evaluation, Allergy and AcademyHealth, the Allergy & Asthma Network Asthma Network; and Judith Woodfolk, MBChB, and GlaxoSmithKline. PhD, professor of medicine, division of asthma, allergy and immunology, department of medicine, Event panelists included Tyra Bryant-Stephens, University of Virginia School of Medicine. The MD, medical director, community asthma preven- event was moderated by Eleanor Perfetto, PhD, tion program, Children’s Hospital of Philadelphia; MS, senior vice president of strategic initiatives, Peter Gergen, MD, medical officer, allergy, asthma National Health Council. Patient-Centered Research on Mental Health On June 13, 2018, Research!America hosted a of psychiatry, Georgetown University Medical briefing on Capitol Hill to explore advances in Center; Patrick Corrigan, PsyD, distinguished patient-centered research that have the potential to professor of psychology, Illinois Institute of improve mental health care. The Patient-Centered Technology; Marilyn Perez-Aviles, research Outcomes Research Institute, the National Medical assistant, Illinois Institute of Technology; and Association and the National Hispanic Medical Elena Rios, MD, MSPH, FACP, president and chief Association supported the briefing. executive officer, National Hispanic Medical Association (NHMA). The event featured remarks Featured panelists included Sonya Ballentine, by Diane Bild, MD, MPH, acting chief science project manager, Illinois Institute of Technology officer, PCORI and was moderated by Andrew College of Psychology; Alfiee Breland-Noble, Sperling, director, legislative and policy advocacy, PhD, MHSc, associate professor, department National Alliance on Mental Illness (NAMI). Research on Workplace Accommodations for Migraine Sufferers Employees who suffer from migraines and executive director, Coalition for Headache and other chronic severe headaches tend to report Migraine Patients (CHAMP), and panelists included lower job performance and may be absent more Eileen Brewer, migraine patient and director of often than other workers. On October 3, 2018, communication and education, Clusterbusters; Research!America hosted a briefing, “Research Amy Miller, PhD, president and chief executive on Workplace Accommodations for Migraine officer, Society for Women’s Health Research; and Sufferers.” It was moderated by Kevin Lenaburg, Stacey Worthy, JD, counsel, Aimed Alliance. Oral Health is Systemic Health Recent research suggests that oral health is Palmolive Company; Martha J. Somerman, DDS, closely tied to overall physical health and poor PhD, director, National Institute of Dental and (L to R) Martha J Somerman, oral health could play a role in a wide range of Craniofacial Research, National Institutes of DDS, PhD; Marco Vujicic, health conditions. In partnership with Colgate, Health; Marko Vujicic, PhD, chief economist and PhD; Maria Emanuel Ryan, DDS, PhD; Research!America hosted a briefing, “Oral Health vice president, Health Policy Institute, American Beth Truett, BS, MDiv is Systemic Health: An Unmet Public Health Dental Association. The event was moderated by Challenge.” Panelists included Maria Ryan, PhD, Beth Truett, BS, MDiv, president and chief execu-
vice president and chief dental officer, Colgate tive officer, Oral Health America. 3
Bipartisan Civic Engagement
Early career scientists have shown increased Groups funded by the Initiative were the Graduate and interest in civic engagement and elevating the Professional Student Senate Science and Policy Group at the University of Washington; the Science Policy Group importance of science to both the public and at the University of California, San Francisco; Vanderbilt policymakers. To support this, Research!America Science Policy Group at Vanderbilt University; Johns Hopkins launched the Bipartisan Civic Engagement Science Policy Group at Johns Hopkins University; Catalysts Initiative with the National Science Policy for Science Policy at the University of Wisconsin, Madison; Network by providing microgrants to 10 science Science Policy Initiative at the University of Virginia and Cville Comm-UNI-ty; SciPAC (Science Policy, Advocacy, policy student groups to increase their level of and Communication) at the University of California San outreach to candidates before the 2018 midterm Diego; Missouri Science and Technology Policy Fellows elections. For their initiatives, these groups at the University of Missouri; The Science Policy Group at hosted op-ed writing workshops, roundtable the University of Illinois at Urbana-Champaign; and South discussions, community science events, social Carolina Psychiatric Association and South Carolina Medical Association Student Sections at the Medical University of media engagements and panel discussions to South Carolina. increase awareness of the benefits of research. Group and event successes were measured by Funding for the Initiative was provided by these generous public attendance, engagement metrics and sponsors: American Association for the Advancement of Science, American Astronomical Society, American Chemical the ability of the events to generate sustainable Society, American Institute of Physics, American Physical models for future engagement. Society, American Psychiatric Association, American Society for Microbiology, Association for Psychological Science, Coalition for the Life Sciences, Federation of Associations in Behavioral & Brain Sciences, International Association for Dental Research, the Optical Society (OSA), Rita Allen Foundation, Sigma Xi, Society for Neuroscience and Supporters of Agricultural Research Foundation (SoAR). Post-Election Briefing
Journalists, former members of Congress, and Next, a panel led by PBS NewsHour’s Yamiche former congressional staff members discussed Alcindor explored the implications of the election how funding for science and medical research for medical and health research and devel- could fare in the new 116th Congress at opment. Panelists included the Hon. Michael Research!America’s Post-Election Briefing on N. Castle, Research!America board chair and November 8, 2018. Reid Wilson, national corre- partner, DLA Piper; the Hon. John Edward Porter, spondent for The Hill, set the stage by highlighting Research!America chair emeritus; the Hon. Bart big trends in the election and framed the chal- Gordon, Research!America board member and lenge facing science advocates today: “Science is partner, K&L Gates LLP; and Sudip Parikh, PhD, rarely at the top of the political agenda because it Research!America board member and senior vice LEFT feels so big,” he said. president and managing director, DIA Americas. (L to R) Yamiche Alcindor; The panelists agreed that while some areas of The Honorable Following Mr. Wilson’s discussion, Rachel Owen, science funding have a positive outlook, there Michael N. Castle; cofounder of the Missouri Science and Technology The Honorable Bart will be competition for limited funds and seques- Gordon; Sudip Parikh, Policy Fellows Program (MOST), presented on tration presents a significant concern. The panel PhD; The Honorable MOST’s science policy café where scientists John Edward Porter concluded with a clear call to action: “Advocacy shared their research with candidates, hosted matters!” rallied Mr. Porter; “Get out there and RIGHT through Research!America’s Bipartisan Civic advocate and work for what you believe in.” Rachel Owen Engagement microgrant program.
4 New Thinking on Persistent Challenges 2018 National Health Research Forum
Research!America’s 2018 National Health PANEL 2: UNMET MEDICAL NEEDS: Research Forum, held September 6, 2018, at SPEEDING PROGRESS AGAINST the Newseum’s Knight Conference Center in TREATMENT-ELUSIVE HEALTH THREATS Washington, D.C., explored a range of topics that are front and center as the nation leverages MODERATOR research to overcome health threats. From Jackie Judd, Health Care Communications Consultant discussing emerging strategies for better health to considering challenges and opportunities PANELISTS regarding treatment-elusive health threats to Gary M. Cohen, Executive Vice President, Global checking in on the hugely ambitious and critically Health, BD; Mikael Dolsten, MD, PhD, President, important Brain Initiative, this year’s forum Worldwide Research and Development, Pfizer; captured the sense of urgency, possibility and Guillermo Prado, PhD, Dean, Graduate School, unwavering determination that is empowering University of Miami; Srini Ramanathan, PhD, science to create a healthier future for Americans Vice President, Development Sciences, Horizon and populations across the globe. Pharma; Robert Redfield, MD, Director, Centers for Disease Control and Prevention; Adrienne The forum opened with a networking breakfast Shapiro, Founder, Axis Advocacy; Celia Witten, featuring National Journal Politics editor Josh PhD, MD, Deputy Director, CBER, Food and Drug Kraushaar, who shared insights on the midterm Administration elections and ever-evolving political landscape.
Three panel discussions followed. PANEL 3: BRAIN SCIENCE: A CLOSER LOOK AT OPPORTUNITIES, OBSTACLES PANEL 1: REIMAGINING MEDICAL AND THE PATH FORWARD PROGRESS: TRENDS, TOOLS AND MODERATOR PARTNERSHIPS THAT ARE RESHAPING Erin Durkin, Health Care and Congressional THE FUTURE OF HEALTH Correspondent, National Journal MODERATOR Mark McClellan, MD, PhD, MPA, Director, Duke- PANELISTS Robert J. Margolis MD Center for Health Policy, Alfiee Breland-Noble, PhD, MHSc, Associate Duke University Professor, Department of Psychiatry, Georgetown University Medical Center; Francis Collins, MD, PANELISTS PhD, Director, National Institutes of Health; France Ivor Benjamin, MD, FAHA, FACC, President, Cordova, PhD, Director, National Science Foundation; American Heart Association; Luiz Miguel Camargo, Paula Dumas, Chief Executive Officer and Managing PhD, Director, Innovation Networks, UCB, Inc.; Tim Editor, Migraine Again; Susan Fitzpatrick, PhD, Hoctor, Vice President, Professional Services Life President and Chief Executive Officer, James S. LEFT Science, Elsevier; Gopal Khanna, Director, Agency McDonnell Foundation; Husseini Manji, MD, FRCPC, Sec. Alex M. Azar II. for Healthcare Research and Quality; Ann Palmer, Global Therapeutic Area Head, Neuroscience, President and Chief Executive Officer, Arthritis Janssen Research & Development, LLC RIGHT Foundation; Joe Selby, MD, MPH, Executive (L to R) The forum closed with a one-on-one discussion Jackie Judd; Celia Director, Patient-Centered Outcomes Research between journalist and health policy expert Susan Witten, MD, PhD.; Institute; Greg Simon, President, Biden Cancer Guillermo Prado, Dentzer and Department of Health and Human PhD.; Adrienne Initiative, Biden Foundation Services Sec. Alex M. Azar II. Shapiro
5 2018 Advocacy Awards
The 2018 Advocacy Awards honored outstanding advocates for research whose contributions bol- stered the nation’s scientific enterprise, both at home and abroad. The honorees were recognized for their achievements in research advocacy on March 14, 2018, at the Andrew W. Mellon Auditorium in Washington, D.C.
LEGACY AWARD GEOFFREY BEENE FOUNDATION GENEROUSLY SUPPORTED BUILDERS OF SCIENCE AWARD BY ANN LURIE Roger I. Glass, MD, PhD, director, The Hon. John Edward Porter, chair Fogarty International Center, for his emeritus of Research!America for his impressive 30-year career as a leader decades-long commitment to advanc- in research and promotion of global ing medical and health research. Porter health, specifically related to his work served as a U.S. congressman (IL-10) in the prevention of gastroenteritis. from 1980 to 2001, during which time (L to R) Mara Hutton, (L to R) Amy Porter; Ann he chaired the House Appropriations Dr. Roger I. Glass Lurie; Research!America Chair Subcommittee on Labor, Health and GORDON AND LLURA GUND Emeritus John E. Porter Human Services, Education, and LEADERSHIP AWARD Related Agencies. He was instrumental Shari and Garen Staglin, cofounders, in doubling the funding for the National One Mind and founders, Staglin Family Institutes of Health over five years. In Vineyard, for their commitment to his honor, as of 2019, the award will be accelerating cures for brain disorders renamed the Honorable John Edward through scientific research. The Porter Legacy Award Generously Staglins have actively given back to the Supported by Ann Lurie. community and supported charitable causes for 45 years. Their focus on (L to R) The Hon. Michael N. brain health research is the result EDWIN C. WHITEHEAD Castle, House Democratic Leader Nancy Pelosi, Shari and of their son Brandon’s diagnosis of AWARD FOR MEDICAL Garen Staglin schizophrenia in 1990. RESEARCH ADVOCACY The Hon. Susan Collins, U.S. senator (R-ME), for her leadership in increasing RESEARCH!AMERICA federal funding for research. She is AWARD FOR SUSTAINED founder and cochair of both the Senate NATIONAL LEADERSHIP Alzheimer’s Task Force and Senate Peter J. Hotez, MD, PhD, dean for the Diabetes Caucus. Her advocacy led to National School of Tropical Medicine, The Hon. Susan Collins a $2 billion increase for the National Baylor College of Medicine, for his Institutes of Health, including a far-reaching work in the areas $414 million increase for Alzheimer’s of neglected tropical disease research research, the largest in history. (L to R) Dr. Peter J. Hotez, and vaccine development. Research!America Vice Chair The Hon. Kweisi Mfume ISADORE ROSENFELD PAUL G. ROGERS AWARD FOR IMPACT ON DISTINGUISHED ORGANIZATION PUBLIC OPINION ADVOCACY AWARD Atul Gawande, MD, MPH, professor, EveryLife Foundation for Rare Diseases department of health policy and man- for their work to bring cures and treat- agement, Harvard T.H. Chan School ments to rare disease patients. The of Public Health; Samuel O. Their EveryLife Foundation works tirelessly to professor of surgery, Harvard Medical improve the regulatory process for drug School; and executive director, Ariadne development—from clinical trials to (L to R) Research!America President and CEO Mary Labs, for dramatically raising the (L to R) Florence “Pippy” approval—by working with patient orga- Woolley; Dr. Atul Gawande; profile of health systems research and Rogers, Dr. Emil D. Kakkis, Max nizations, industry, academic scientists, Research!America Board Schill, Research!America Board Member Tenley E. Albright, MD promoting evidence-based research to member Laing Rogers the Food and Drug Administration and improve health-care delivery. the National Institutes of Health to bring about key policy changes.
6 Experts Discuss Science Advocacy and Mental Health at Research!America’s Annual Meeting
Advocating for science funding is essential NIMH including [mental health] screenings in the to maintain the nation’s global leadership in emergency department settings.” Wayne Drevets, research and development, according to Rep. MD, scientific vice president and disease area Eddie Bernice Johnson (D-TX-30), ranking member leader, mood disorders, neuroscience therapeutic of the U.S. House of Representatives Committee area, Janssen Research & Development, said on Science, Space, and Technology. She was the promising new studies of biomarkers could help keynote speaker at Research!America’s 29th doctors better zero in on effective treatments for Annual Meeting of Members on March 14, 2018, individual patients. in Washington, D.C. “We’re really falling far short of nurturing our own homegrown STEM talent,” Many advances in how doctors treat psychiatric she said, adding that minority youth should be conditions involve both neuroscience and encouraged to pursue careers in science, technol- engineering, expressed Kafui Dzirasa, MD, PhD, ogy, engineering and math. associate professor of psychiatry and behavioral sciences, Duke Institute for Brain Sciences. “That The annual meeting also featured a discussion is happening in terms of constructing new tools TOP about the latest developments in mental health and devices to get information out of the brain (L to R) Joyce Frieden; Dr. Linda Brady; research. MedPage Today news editor Joyce at the speed at which thoughts happen,” he said. Dr. Kafui Dzirasa; Frieden moderated. Linda Brady, PhD, director, One Mind president and patient advocate Brandon Dr. Wayne Drevets; division of neuroscience and basic behavioral Staglin encouraged advocates to learn all they can Brandon Staglin science, National Institute of Mental Health (NIMH) about the amazing science that is changing brain CIRCLE stated that one of the institute’s goals is to reduce health and to share that information with family, Congresswoman the suicide rate by 20% by 2025, saying, “There friends and lawmakers. Eddie Bernice Johnson (D-TX-30) have been a lot of initiatives rolled out of the
7 Webinars
Science Advocacy Continuing a series that was launched in On April 18, 2018, the webinar “Inspiring Others to 2017, Research!America and the Society for be Science Advocates” provided individuals of sci- Neuroscience hosted three webinars on science ence with tools on how to motivate and empower advocacy. The first webinar, “Strategies to their science and non-science peers to partake Maximize Your Advocacy Results,” was held on in science advocacy. Panelists included Monica February 23, 2018, and provided science advo- Linden, PhD, senior lecturer at Brown University; cates with up-to-date, applicable information on Cynthia Gibbs, founder and director of Science the most effective ways to advocate for a move- Pub RVA; and Rick Karnesky, PhD, co-boss, Nerd ment. Speakers included Sudip S. Parikh, PhD, Nite East Bay. senior vice president and managing director, DIA Americas, and Research!America board member; Finally, on June 1, 2018, the webinar “Measuring Pete Kirkham, president and founder of Red Advocacy Outcomes” provided viewers with Maple Consulting; and Lori L. McMahon Wakefield, clarity on measuring outcomes for advocacy suc- PhD, dean of UAB Graduate School, Jarman F. cess. This webinar featured the Hon. Bart Gordon, Lowder Professor of Neuroscience, and director of partner, K&L Gates LLP and U.S. Representative, Comprehensive Neuroscience Center, University of 1985–2011; Carlisle Levine, PhD, president and Alabama at Birmingham. chief executive officer, BLE Solutions (Arlington, VA); Annette L. Gardner, PhD, MPH, assistant professor, Philip R. Lee Institute for Health Policy Studies, University of California–San Francisco.
Migraine Series Migraines pose a unique set of challenges to current status of research on migraine and how those who suffer from them, as well as to provid- this knowledge can be translated into treatment ers tasked with properly diagnosing and treating plans for migraine sufferers. Presenters for them. To provide more information and insight this webinar included Lisa DeLeonardo, PsyD, on the challenges of migraine, Research!America licensed psychologist and migraine patient; Peter and Amgen hosted a series of webinars that McAllister, MD, medical director, New England built upon a 2017 survey on the topic. The first Institute for Neurology and Headache and chief webinar, “What Are the Barriers in Advancing medical officer, New England Institute for Clinical Migraine Research?,” was held on April 11, 2018, Research and Ki Clinical Research; and Jan Lewis on the topic of prevention, research and new Brandes, MD, MS, founder, Nashville Neuroscience discoveries made that increase the chances Group and assistant clinical professor, Department that the right treatment is given to the right of Neurology, Vanderbilt. patient at the right time. This webinar featured Michael L. Oshinsky, PhD, program director, pain Finally, to discuss obstacles blocking a future and migraine, National Institute of Neurological free from the grasp of migraine, “Connecting the Disorders and Stroke, National Institutes of Dots: What Will It Take to Meet the Challenge of Health; Robert E. Shapiro, MD, PhD, department Migraine?,” was held on December 11, 2018. This of neurological sciences, Larner College of webinar featured Suchitra Iyer, PhD, Center for Medicine, University of Vermont; and Katie M. Evidence and Practice Improvement, Agency for Golden, professional migraine patient. Healthcare Research and Quality; Alicia Torborg, executive director, Association of Migraine The second webinar in the series, “The Value Disorders and migraine patient; and Lindsay of Evidence-Based Treatments for Migraine Videnieks, JD, executive director of the Headache Sufferers” was held on June 12, 2018, on the and Migraine Policy Forum. 8 Public Opinion Partnerships
Vaccines and Infectious Diseases In general, to what extent do you think infectious and emerging diseases facing other countries will In May 2018, Research!America worked with the American Society for Microbiology to assess the pose a threat to the U.S. in the next few years?
public’s knowledge of and opinions on vaccines and SOURCE: A RESEARCH!AMERICA SURVEY OF U.S. ADULTS CONDUCTED IN infectious diseases. The overwhelming majority of PARTNERSHIP WITH ZOGBY ANALYTICS IN MAY 2018. those surveyed reported that they believed emerging and infectious diseases in other countries will pose 4% either a major or minor threat to those in the United will not pose a threat to the U.S. States in the future. Results of the survey were shared at a briefing at the Newseum in Washington, D.C. Speakers included Anthony S. Fauci, MD, director, 46% 49% National Institute of Allergy and Infectious Diseases; will pose a will pose a Nancy Messonnier, MD, director, National Center for major threat minor threat to the U.S. to the U.S. Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; and Stacey L. Schultz- Cherry, PhD, president, American Society for Virology. Child Abuse and Neglect In June of 2018, Research!America joined in the Do you view child abuse and neglect as a movement to treat child abuse and neglect as a public health problem in the United States? public health issue, not just a social or legal issue. SOURCE: A RESEARCH!AMERICA SURVEY OF U.S. ADULTS CONDUCTED IN A partnership was launched with the National PARTNERSHIP WITH ZOGBY ANALYTICS IN JUNE 2018. Foundation to End Child Abuse and Neglect (EndCAN) to pioneer a movement of conducting research on how to prevent adverse childhood events. Across 14% racial and party lines, the majority of Americans no believed that child abuse and neglect is a serious or moderate problem in the United States and placed 9% increasing federal government funding to research don’t know/ 78% refused child abuse and neglect at a high priority. This yes survey information was shared at events in Colorado and Washington, D.C., in partnership with EndCAN. Featured speakers included Richard D. Krugman, MD, EndCAN cofounder and distinguished professor of pediatrics, University of Colorado School of Medicine; Lori Poland, cofounder, EndCAN; Colorado Gov. John Hickenlooper; Mary Woolley, chief executive officer and president, Research!America; and many others. How concerned are you that antibiotic resistance will make more infections difficult or impossible to treat and even deadly? Antibiotic Resistance SOURCE: A RESEARCH!AMERICA SURVEY OF U.S. ADULTS CONDUCTE A pervasive health threat facing Americans today is the IN PARTNERSHIP WITH ZOGBY ANALYTICS IN OCTOBER 2018. risk of developing an antibiotic resistant infection. In October 2018, Research!America partnered with Pfizer and the Infectious Disease Society of America to assess 42% public knowledge of and opinions regarding antibiotic very 39% concerned somewhat resistance. More than 80% of those surveyed reported concerned that they were concerned that antibiotic resistance will make infections harder to treat and possibly deadly in the upcoming future, and 65% confirmed they believe 10% that antibiotic resistance is a public health problem. not too concerned 3% 7% These results also revealed an opportunity for further not at all not sure concerned education. For example, 37% of respondents wrongly stated that antibiotics are effective in treating viral infections. This information was widely shared during World Antibiotic Awareness Week in November 2018. 9 Science Communications Presentations
Public opinion surveys commissioned by scientists at all levels by visiting a range of Research!America have established the essential universities to present and discuss with scientists “invisibility” of scientists and science-based how vital their voice is, giving them the informa- institutions among the American public, which tion and tools they need to truly put a human is a contributing factor to science skepticism. face on science with the public that will bridge Research!America has seen firsthand that the a divide that has become perilously wide. These most effective way to reach non-scientists, includ- Kavli Lectures, presented by Research!America’s ing those who formulate policy for the nation, president Mary Woolley and staff members, were is for scientists themselves to make the case as included among the interactive science commu- to why their work matters in a host of ways that nication and engagement seminars held at 18 contribute to a productive, prosperous society. universities across the country. These programs With partial funding from the Kavli Foundation, provide scientists with inspiration to share the Research!America committed to engage with excitement of science with the public. Public Health Thank You Day
On Monday, November 19, 2018, Research!America Several public health and civic leaders lent and 60 partner organizations celebrated Public their voices to emphasizing the value of public Health Thank You Day (PHTYD) to show appreci- health, including Centers for Disease Control ation for public health professionals who work to and Prevention director Robert R. Redfield, MD; keep the nation healthy and secure. This year’s Centers for Medicare and Medicaid Services outreach strategy focused on messaging during administrator Seema Verma; National Institutes the week leading up to PHTYD, successfully of Health director Francis S. Collins, MD, PhD; increasing Research!America’s influence on Department of Health and Human Services Sec. Twitter by 10% over last year and highlighting the Alex M. Azar II; Assistant Sec. of Health Brett P. crucial role the public health workforce plays in Giroir, MD; Surgeon General Jerome M. Adams, the nation and across the globe. MD, MPH; Sen. Catherine Cortez Masto (D-NV); Rep. Marcia L. Fudge (D-OH-11); Rep. Val Demings (D-FL-10); Rep. Linda Sanchez (D-CA-38); Harold MORE THAN Paz, MD, MS, executive vice president and chief 60 medical officer, Aetna; Derek Rapp, chief executive officer, JDRF; Rachel Levine, MD, secretary of ORGANIZATIONAL 4.4 mil health for the Commonwealth of Pennsylvania; PARTNERS ACCOUNTS president of the Albert and Mary Lasker Foundation Claire Pomeroy, MD, MBA; and presi- REACHED ON dent-elect of APHA Lisa Carlson, MPH, MCHES TWITTER 22 2018 PUBLIC HEALTH QUOTES FROM NEARLY THANK YOU DAY ACTION PHTYD Congressional Resolution: H.Con.Res.141 PUBLIC HEALTH 800 In honor of this important day, cochairs of the LEADERS House Public Health Caucus, Reps. Wittman FACEBOOK (R-VA-1), Granger (R-TX-12), McGovern (D-MA-2) MORE THAN ACCOUNTS and Roybal-Allard (D-CA-40) introduced a res- olution (H.Con.Res.141) expressing the sense of REACHED Congress that public health professionals should be commended for their dedication and service to 11 mil the United States on Public Health Thank You Day, DOZENS OF November 19, 2018. Research!America IMPRESSIONS President and CEO TWEETS FROM Mary Woolley ON TWITTER INFLUENTIAL LEADERS 10 U.S. Investments in Medical and Health Research and Development (R&D)
Total U.S. investment in medical and health R&D in the 27% United States grew by 27% over the TOTAL INVESTMENT GROWTH five-year period FROM 2013 TO 2017 from 2013 to 2017, led by industry and the federal govern- TOTAL U.S. MEDICAL AND ment, according to Research!America’s HEALTH R&D SPENDING WAS report U.S. Investments in Medical and Health $181.5 bil Research and Development. “Overall, U.S. invest- IN 2017 ments in health-related research and development continue to move in a positive direction, but it’s important to consider whether this investment INDUSTRY INVESTED is enough to overcome health threats that are taking lives, reducing productivity, and sin- gle-handedly placing our fiscal future at risk,” $121.8 bil said Research!America’s chair, the Hon. Michael N. Castle. “Our nation cannot afford less than a IN MEDICAL AND HEALTH full-court press against deadly and debilitating R&D, 67% OF TOTAL health threats. The returns—both quantitative and qualitative—on medical and health R&D dwarf our SPENDING IN 2017 investment. It is heartening that we are on the right path, but it’s time to dramatically step up our game,” said Mary Woolley, president and chief FEDERAL AGENCIES executive officer, Research!America. INVESTED A TOTAL OF $39.5 bil, WITH THE NATIONAL INSTITUTES OF HEALTH ACCOUNTING FOR NEARLY $32.4 BILLION (OR 82.1%) OF FEDERAL SPENDING IN 2017
11 Media Matters
Research!America’s survey data continued to earn high levels of media coverage in 2018, particularly the surveys related to public health, vaccines and antimicrobial resistance. Media coverage also highlighted efforts in funding advocacy and policy and advocating for science. Online, print, broadcast and digital media highlights include the following:
• In January 2018, The Huffington Post fea- • The June 2018 issue of Scientific American tured Research!America’s survey data in included an op-ed and coverage of the an op-ed, “The Public Disengagement with Bipartisan Candidate Engagement Initiative. Science.” Former U.S. Rep. Ron Paul (TX) also • In July, Research!America’s survey on child cited Research!America’s survey data in his abuse and neglect and the launch of End Newsweek article calling for a repeal of the Child Abuse Now (EndCAN) received extensive medical device tax. coverage on television news, particularly in the • Following the passage of the FY18 omnibus Denver region. spending bill in March 2018, Research!America’s • In September 2018, Woolley was quoted in chief executive officer and president Mary Politico and MedPageToday regarding the Woolley was quoted in CQ Roll Call, The release of the final version of the FY19 Scientist and U.S. News & World Report. Labor-HHS bill. • In April 2018, Woolley talked to The Washington • Results and findings from Research!America’s Post and Buzzfeed about the importance of the survey on antibiotic resistance in November March for Science in reminding the public and 2018 were featured in numerous media outlets, policymakers of how essential it is to fund and including The Washington Examiner, The support science. She also published a letter to Hill, HealthDay, U.S. News & World Report, the editor of the . Indiana Journal and Courier BioTechNow and Infection Control Today. • Research!America’s May 2018 vaccine survey • As the federal government approached a results were featured in MedPage Today, contentious shutdown in December 2018, NBC News and affiliates,U.S. News & World Research!America’s vice president of policy Report, The Hill, NewsMax, Fortune, Homeland and advocacy Ellie Dehoney was quoted in and Preparedness News Advance Healthcare Bloomberg Law about the effects on the Food Network during May and June 2018. and Drug Administration.
TWITTER FOLLOWERS TOTAL MEDIA IMPRESSIONS 11,632 723 MILLION 5.2% increase since 2017 MENTIONS IN MORE THAN 60 FACEBOOK PAGE LIKES NATIONAL AND TRADE PUBLICATIONS 3,972 10.3% increase since 2017 139 WEBSITE UNIQUE PAGE USERS PRESS RELEASES AND STATEMENTS
12 287,004 24 Financials
Research!America Financial Statements for the Year Ended December 31, 2018
REVENUE & SUPPORT EXPENSES Contributions & Grants $619,515 Program $3,061,453 72.7% Membership Dues $1,515,100 Fundraising $607,450 14.4% Program Support $1,087,400 Administrative $542,766 12.9% Advocacy Awards Event $721,150 Total Expenses* $4,211,669 Other $34,832 In-Kind Support $84,770 Total Revenue and Support* $4,062,767
Balance Sheet
ASSETS NET ASSETS Cash & Equivalents $322,768 Temporarily Restricted Funds $1,521,624 Contributions Receivable $1,224,097 Unrestricted Funds $512,728 Investments $954,067 Total Net Assets* $2,034,352 Property & Equipment $455,784 Other Assets $427,668 CHANGE IN NET ASSESTS Total Assets* $3,384,384 Net Assets at the Beginning of 2018 $2,236,025 Results from Operations ($148,902) LIABILITIES Realized and Unrealized Losses ($52,571) Accounts Payable $11,722 Change in Net Assets* ($201,473) Accrued Expenses $211,247 Deferred Rent $723,477 Other Liabilities $403,586 Total Liabilities* $1,350,032
Audit Committee Amy Comstock Rick, JD Chair * SUMMARY INFORMATION FROM UNAUDITED FINANCIAL STATEMENTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 Tenley Albright, MD AUDITED FINANCIAL STATEMENTS, WHEN AVAILABLE, WILL BE Larry Hausner, MBA PROVIDED UPON REQUEST. James Madara, MD A COPY OF RESEARCH!AMERICA’S MOST RECENTLY FILED IRS Derek Rapp FORM 990 IS AVAILABLE ON RESEARCH!AMERICA’S WEBSITE. Gary Reedy RESEARCH!AMERICA AUDITORS: TATE & TRYON
13 2018 Major Donors, Partners, and Contributors VISIONARIES $100,000+ American Psychiatric Rush D. Holt, PhD Dennis A. Ausiello, MD Association International & American Autism Speaks Amgen Astellas Pharma US, Inc. Association for Dental The Baltimore Family Fund Celgene Corporation Battelle Research Paul Berg, PhD Janssen Pharmaceutical Baylor College of Medicine International Biomedical Coalition for the Life Companies of Johnson & Bristol-Myers Squibb Research Alliance Sciences Johnson Case Western Reserve The Jackson Laboratory Mike Coburn The Kavli Foundation University School of Harry Johns Deloitte Pfizer Inc Medicine Johnson & Johnson Joe Doyle CHAMPIONS $50,000–$99,999 Children’s National Medical Elizabeth Baker Keffer Federation of American Center Debra R. Lappin, JD Societies for Experimental Albert and Mary Lasker The Dana Foundation Alan I. Leshner, PhD Biology (FASEB) Foundation ExlService Holdings, Inc. Mary Ann Liebert Federation of Associations American Medical Faegre Baker Daniels James L. Madara, MD in Behavioral & Brain Association Consulting Lucinda L. Maine, PhD, RPh Sciences Burroughs Wellcome Fund The George Washington The Hon. Kweisi Mfume Foundation for a Smoke- Horizon Pharma University School of National Disease Research Free World Ann Lurie Medicine and Health Interchange (NDRI) Foundation for Biomedical Patient-Centered Outcomes Sciences NewYork–Presbyterian Research Research Institute (PCORI) GlaxoSmithKline Hospital Foundation for the National Sanofi Mary J. C. Hendrix, PhD Harold L. Paz, MD, MS Institutes of Health Society for Neuroscience Emil D. Kakkis, MD, PhD Guillermo J. Prado, PhD Gates Center for Takeda Pharmaceuticals NEOMED Foundation E. Albert Reece, PhD, MBA Regenerative Medicine UCB, Inc. Northwestern University Linda Reed Jill Giroir The University of Chicago One Mind Gary M. Reedy Karen A. Goraleski Susan Whitehead Partners HealthCare Laing Rogers Holland & Knight LLP PARTNERS $25,000–$49,999 System Sanford Research The Johns Hopkins PhRMA Larry J. Shapiro, MD University AdvaMed (Advanced University of California, Los The Optical Society Johnathan S. Kahan Medical Technology Angeles Sigma Xi: The Scientific Patricia Kammerer Association) University of California, San Research Honor Society Liles Parker, PLLC Aetna, Inc. Francisco Spectrum Science Mary Fogarty McAndrew Alzheimer’s Association Vertex Pharmaceuticals Communications National Association for American Society for Washington University in Supporters of Agricultural Biomedical Research Microbiology St. Louis Research (SoAR) National Eating Disorders BD Whitehead Institute for Foundation Association (NEDA) Geoffrey Beene Foundation Biomedical Research U.S. Pharmacopeial National Foundation for The Gordon and Llura Gund Convention Infectious Diseases Foundation ADVOCATES $1,500–$9,999 Weill Cornell Medicine Gilbert S. Omenn, MD, PhD Howard Hughes Medical Hortensia Amaro, PhD Elias and Nadia Zerhouni Sudip S. Parikh, PhD Institute American Association for William A. Peck, MD The Kempe Foundation Cancer Research SUPPORTERS $500–$1,499 The Hon. John Edward Lilly American Association of American Association of Porter Merck & Co., Inc. Colleges of Pharmacy Pharmaceutical Scientists Joshua C. Rubin, JD, MBA, Rita Allen Foundation American Astronomical American Diabetes MPH, MPP Rogers Family Foundation Society Association Gregory Sawers Rosenfeld Heart American Chemical Society American Public Health William T. Schmidt Foundation American Educational Association Samuel C. Silverstein, MD Mary Woolley Research Association American Society of Texas State University INNOVATORS $10,000–$24,999 American Institute of Tropical Medicine and Reed V. Tuckson, MD, FACP Physics Hygiene University of Colorado AcademyHealth American Society of Human Deborah T. Ashford and Anschutz Medical Campus Tenley E. Albright, MD Genetics Kevin Klose University of Illinois at American Association Henry S. Bienen, PhD Association for Chicago College of for the Advancement of Bloomberg Philanthropies Psychological Science Medicine Science Nancy Brown Association for Research in University of Maryland, American Cancer Society The Hon. Michael N. Castle Vision and Ophthalmology School of Medicine American Geophysical Susan M. Fitzpatrick, PhD Association of American University of Texas Medical Union The George Washington Cancer Institutes Branch at Galveston American Heart Association University Association of Clinical School of Medicine American Physical Society Hogan Lovells US LLP Research Organizations Brian Whalen Martha N. Hill, PhD, RN Audentes Therapeutics, Inc.
Research!America Staff Mary Woolley Aimée Lefever Terri Schwartzbeck HOWARD HUGHES MEDICAL President and CEO Director of Operations Senior Manager of INSTITUTE SCIENCE Communications Sara Chang Barbara Love POLICY FELLOWS Director of Advocacy Executive Assistant to the Thayer Surette Programs President Director, Alliance Matthew Davidson, PhD Carly Cox, PhD Michael Coburn Jenny Luray Development and Executive Vice President Senior Advisor Membership BURROUGHS WELLCOME and Chief Operating Officer Donna McKelvey James Taylor FUND INTERNS Ellie Dehoney Vice President, Alliance Manager of Policy and Jennifer Chasseur Vice President, Policy and Development and Advocacy Sonia Dermer Advocacy Membership Erin Whiteman Alison Elliott Alliance Development and Carina Hart Anna Raby Claudia Quarshie Membership Associate Administrative Assistant Communications Specialist Stephanie Sawicki Jacqueline Lagoy Michelle Reddersen Sonya Sternlieb Administrative Coordinator, Controller Samantha Swamy Policy and Advocacy Sally Yin
14 Board of Directors OFFICERS
The Hon. Michael The Hon. John The Hon. Kweisi Mary Woolley, E. Albert Reece, Sudip S. Parikh, N. Castle, Chair Edward Porter, Mfume, Vice Chair President MD, PhD, MBA, PhD, Treasurer Partner, DLA Piper, Chair Emeritus Chief Health Equity Chief Executive Secretary Senior Vice LLP United States Officer, Capital Officer Dean; Executive President and Governor of Representative Technologies Research!America Vice President for Managing Director, Delaware (1980–2001) Informatics Systems Medical Affairs; DIA Americas (1985–1992) Director, Health John Z. and United States Policy Research Akiko Bowers Representative Consortium Distinguished (1993–2011) United States Professor University Representative of Maryland School (1987–1996) of Medicine BOARD MEMBERS American Medical EMERITUS DIRECTORS Jewell Jackson McCabe Association Hortensia Amaro, PhD Catherine E. McDermott Tenley E. Albright, MD Lucinda Maine, PhD, RPh Dennis A. Ausiello, MD Donnica L. Moore, MD Director Executive Vice President and Kenneth I. Berns, MD, PhD James E. Mulvihill, DMD MIT Collaborative Initiatives Chief Executive Officer William R. Brinkley, PhD Elizabeth G. Nabel, MD Georges C. Benjamin, MD American Association of Roger J. Bulger, MD William D. Novelli Executive Director Colleges of Pharmacy G. Steven Burrill William A. Peck, MD American Public Health Gail H. Cassell, PhD Edward E. Penhoet, PhD Mark McClellan, MD, PhD, William L. Roper, MD, MPH Association MPA Wendy Chaite, Esq. Jordan J. Cohen, MD Leon E. Rosenberg, MD Nancy Brown Director, Robert J. Margolis, Charles A. Sanders, MD Chief Executive Officer MD, Center for Health Policy, Sam Donaldson Robert K. Dresing Mitchel Sayare, PhD American Heart Association Duke University Carol R. Scheman Former Administrator, Centers Joseph M. Feczko, MD Susan Dentzer Myron Genel, MD M. Roy Schwarz, MD Visiting Fellow, Robert J. for Medicare and Medicaid Susan C. Scrimshaw, PhD Services (2004–06) Irma E. Goertzen Margolis, MD, Center for M.R.C. Greenwood, PhD John R. Seffrin, PhD Health Policy, Duke University Former Commissioner, Food Randolph Siegel and Drug Administration Elmer E. Huerta, MD, MPH Robert A. Ingram Samuel C. Silverstein, MD Victor J. Dzau, MD (2002–04) The Hon. Louis W. Sullivan, MD President Harry Johns The Hon. Billy Tauzin National Academy of Medicine Herbert Pardes, MD Jackie Lovelace Johnson Executive Vice Chairman, Reed V. Tuckson, MD Susan Fitzpatrick, PhD Evan Jones Board of Trustees The Hon. Patrick J. Kennedy Christopher A. Viehbacher President NewYork–Presbyterian M. Cass Wheeler James S. McDonnell Caroline A. Kovac, PhD Hospital Philip R. Lee, MD John Whitehead Foundation Ruth A. Wooden Harold L. Paz, MD, MS Ellen Levine Jay A. Gershen, DDS, PhD John P. Margaritis Judy Woodruff Executive Vice President and James B. Wyngaarden, MD President Chief Medical Officer Northeast Ohio Medical Aetna, Inc. University Guillermo J. Prado. PhD The Hon. Bart Gordon IN MEMORIAM foundation for targeted Dean of Graduate School, cancer therapies and Partner, K&L Gates LLP Leonard M. Miller Professor Richard Furlaud, JD U.S. Representative (1923–2018) was a vital advocated for increasing of Public Health Sciences, our nation’s support for (1985–2011) Director of Division of force for the advancement of medical science through biomedical research. He William N. Hait, MD, PhD Prevention Science and also served as the director Global Head Community Health, Miller research. As president and chief executive officer of the Sheikh Khalifa Bin Johnson & Johnson Global School of Medicine, University Zayad Al Nahyan Institute External Innovation of Miami of Squibb Beech-Nut, Mr. Furlaud built the company for Personalized Cancer Larry Hausner, MBA Derek K. Rapp into a pharmaceutical Therapy (IPCT), and as President and Chief Executive President giant that eventually the first L. E. and Virginia Officer ConStrat merged into Bristol-Myers Simmons Senior Fellow JDRF Mary J.C. Hendrix, PhD Squibb. He also was a in Health and Technology President Gary M. Reedy founding board member Policy at Rice University’s Shepherd University Chief Executive Officer of Research!America and James A. Baker III Institute for Public Policy. Martha N. Hill, PhD, RN American Cancer recognized by Harvard Dean Emerita Society Business School as a “Great American Business Isadore Rosenfeld, The Johns Hopkins University Amy Comstock Rick, JD MD (1926–2018) was School of Nursing President and Chief Executive Leader of the 20th Century.” After retiring widely recognized as Rush D. Holt, PhD Officer one of the country’s Food and Drug Law Institute from the company in Chief Executive Officer, 1991, Mr. Furlaud became preeminent physicians American Association for the Laing Rogers chairman of American and a renowned Advancement of Science Community Leader Express, International advocate for medical U.S. Representative Larry J. Shapiro, MD Flavors and Fragrances, and health research. (1999–2015) Chief Executive Officer and the Rockefeller Dr. Rosenfeld was a University Health Partners of University board of founding board member Elizabeth Baker Keffer of Research!America and Managing Director and Chief Hawai‘i trustees. established the Isadore Network Officer Gregory Sorensen, MD Rosenfeld Award for BDT & Company Executive Chairman John Mendelsohn, MD (1936–2019) was honored Impact on Public Opinion, Debra R. Lappin, JD IMRIS which honors members of Principal with the Geoffrey Beene Keith R. Yamamoto, PhD Builders of Science the media or individuals Faegre Baker Daniels Professor, Vice Chancellor for who effectively deliver Consulting Award in 2013. During his Science Policy and Strategy; tenure as president of research advocacy Alan I. Leshner, PhD Director of UCSF Precision The University of Texas messages to the public. Chief Executive Officer Medicine MD Anderson Cancer His book, Doctor of the Emeritus University of California–San Center from 1996 to 2011, Heart: My Life in Medicine, American Association for the Francisco he oversaw dramatic recounts his extraordinary Advancement of Science increases in both size and career as a cardiologist Elias A. Zerhouni, MD and “America’s Doctor” James L. Madara, MD Former Director stature of the institute. He pioneered translational during a time of great 15 Chief Executive Officer and National Institutes of Health progress in medicine. Executive Vice President (2002–08) research that provided the NOW Thanks to research, the development of Highly Active Antiretroviral THEN Therapy has revolutionized the battle Most cases of against HIV/AIDS and transformed HIV/AIDS the virus from a death sentence to a were fatal manageable chronic condition
NOW IMAGINE Thanks to research, An HIV vaccine vaccines can prevent and eradication of THEN children from ever HIV/AIDS worldwide In 1900, infectious diseases contracting these such as pneumonia, diseases influenza and tuberculosis took the lives of nearly 25% of all children before they reached age 14
IMAGINE All children growing up healthy and free from all THEN NOW infectious diseases Pronounced problems Thanks to research, with memory, thinking, Alzheimer’s disease is communication, and behavior recognized as a discrete were widely but inaccurately health condition and research considered a normal is fueling new drugs and part of aging other interventions
IMAGINE Aging and thriving without the threat of dementia or Alzheimer’s
Research!America is poised to enter its 30th year. To ensure that it is a year in which faster medical progress, strategic public health investment and research and development leadership take center stage, let’s keep up the community’s strong record of advocacy. All of us at Research!America look forward to working with you to achieve these goals.
16
241 18th Street South Suite 501 Arlington, VA 22202
P 703-739-2577 F 703-739-2372 www.researchamerica.org